Analysts Stock Movers: Otonomo Technologies Ltd (NASDAQ:OTMO), Clene Inc. (NASDAQ:CLNN)

Clene – Charge Up with Clene—Initiate Outperform, $20 PT – Oppenheimer

Clene Inc. (NASDAQ:CLNN) is trading lower by 1.80% in the morning session as Oppco’s Leland Gershell states, “By applying its proprietary metal nanocatalysis technology, Clene is broadly pursuing the treatment of neurodegenerative and other diseases through an innovative bioenergetics approach. Gold-based lead candidate CNM-Au8 has been shown to enhance remyelination and neuroprotection in preclinical models of multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis.

Early Phase 2 indicators of efficacy in these settings support CNM-Au8’s disease-modifying potential, and safety has been unconcerning. A Phase 3 trial in ALS is on track to read out in 2Q22—ahead of which data on motor nerve function, to be revealed next quarter, could be instructive. With CLNN’s potential to realize several multi-billion-dollar revenue opportunities, we see its ~$480M EV as offering attractive risk-reward.”

Otonomo Technologies –  Vertically Focused Data Analytics Platform Poised to Monetize Connected Autos; Initiate at Buy – Needham

Otonomo Technologies Ltd (NASDAQ:OTMO) stock moved up 5% after Needham’s Jack Andrews states, “Operating at the intersection of growing connected car data and big data analytics, OTMO provides a data services platform that securely ingests billions of data points per day from several major OEMs and tens of millions of connected cars to form both a marketplace of data and a growing ecosystem of SaaS-based applications.

We believe OTMO should benefit as the number of connected cars grows in conjunction with the commercialization of a plethora of use cases on its platform. Our scenario analysis points to a favorable risk/reward setup with material upside if management can execute against its large TAM.”